Rule Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting

We portray the clinical endorsement of an assigned DNA and RNA-based front line sequencing (NGS) measure at two clinical sub-nuclear indicative labs. This action uses